Xiaodong Ma

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 8

Top Topics

Idiopathic Pulmonary Fibrosis

Molecular Dynamics Simulations

Breast Cancer Cells

Top Venues

Journal of natural products

ACS medicinal chemistry letters

Oxidative medicine and cellular longevity

This page only lists publications with an associated author ORCID identifier.

Publications

Yan Bai, Xiaodong Ma, Duo Ren, Guoqing Yu, Jiangchun Hu, Hui-Ming Hua, Huaqi Pan
Peniapyrones A-I, Cytotoxic Tricyclic-Fused α-Pyrone Derivatives from an Endophytic Penicillium brefeldianum F4a. Journal of natural products 87 (6) (2024)
Yan Bai, Xiaodong Ma, Duo Ren, Guoqing Yu, Jiangchun Hu, Hui-Ming Hua, Huaqi Pan
Peniapyrones A-I, Cytotoxic Tricyclic-Fused α-Pyrone Derivatives from an Endophytic Penicillium brefeldianum F4a. Journal of natural products (2024)
Yan Bai, Xiaodong Ma, Duo Ren, Guoqing Yu, Jiangchun Hu, Hui-Ming Hua, Huaqi Pan
Peniapyrones A-I, Cytotoxic Tricyclic-Fused α-Pyrone Derivatives from an Endophytic Penicillium brefeldianum F4a. Journal of natural products 87 (6) (2024)
Lin Wang, Maoling Yao, Yuegao Hu, Congdi Chen, Liming Jin, Xiaodong Ma, Hongjun Yang
Synthesis and Antitumor Activity of Diosgenin Hydroxamic Acid and Quaternary Phosphonium Salt Derivatives. ACS medicinal chemistry letters 13 (5) (2022)
Lixue Chen, Shengnan Li, Yanfang Ding, Changyuan Wang, Sitong Zhang, Ruping Xu, Yali Chen, Hang Li, Meng Gao, Yan Qi, Youwei Xu, Xiaodong Ma, Lei Li
Honokiol Prodrug Nanoparticles Based on In Situ Albumin Binding for Long Circulation and High Tumor Uptake. ACS medicinal chemistry letters 12 (10) (2021)
Jiangnan Zhang, Tingting Zhao, Changyuan Wang, Qiang Meng, Xiao-Kui Huo, Chong Wang, Pengyuan Sun, Huijun Sun, Xiaodong Ma, Jingjing Wu, Ke-Xin Liu
Catalpol-Induced AMPK Activation Alleviates Cisplatin-Induced Nephrotoxicity through the Mitochondrial-Dependent Pathway without Compromising Its Anticancer Properties. Oxidative medicine and cellular longevity 2021 (2021)
Bo Sun, Xiaowen Liu, Xu Zheng, Changyuan Wang, Qiang Meng, Huijun Sun, Xiaohong Shu, Kexin Liu, Xiuli Sun, Yanxia Li, Xiaodong Ma
Novel Pyrimidines as Multitarget Protein Tyrosine Kinase Inhibitors for the Treatment of Idiopathic Pulmonary Fibrosis (IPF). ChemMedChem 15 (2) (2019)
Yuanyuan Yi, Luhong Wang, Dan Zhao, Shanshan Huang, Changyuan Wang, Zhihao Liu, Huijun Sun, Kexin Liu, Xiaodong Ma, Yanxia Li
Structural optimization of diphenylpyrimidine scaffold as potent and selective epidermal growth factor receptor inhibitors against L858R/T790M resistance mutation in nonsmall cell lung cancer. Chemical biology & drug design 92 (6) (2018)